Production (Stage)
Applied Therapeutics, Inc.
APLT
$0.4099
-$0.0001-0.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 122.00K | 144.00K | 190.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 122.00K | 144.00K | 190.00K |
| Cost of Revenue | 7.84M | 11.70M | 14.83M | 10.00M | 12.22M |
| Gross Profit | -7.84M | -11.70M | -14.71M | -9.86M | -12.03M |
| SG&A Expenses | 17.69M | 21.33M | 15.04M | 10.58M | 9.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.53M | 33.02M | 29.87M | 20.58M | 21.28M |
| Operating Income | -25.53M | -33.02M | -29.74M | -20.44M | -21.09M |
| Income Before Tax | -21.83M | 44.01M | -68.59M | 2.90M | -83.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.83M | 44.01M | -68.59M | 2.90M | -83.94M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.83M | 44.01M | -68.59M | 2.90M | -83.94M |
| EBIT | -25.53M | -33.02M | -29.74M | -20.44M | -21.09M |
| EBITDA | -25.52M | -33.02M | -29.74M | -20.44M | -21.09M |
| EPS Basic | -0.15 | 0.30 | -0.48 | 0.02 | -0.67 |
| Normalized Basic EPS | -0.09 | 0.19 | -0.30 | 0.01 | -0.42 |
| EPS Diluted | -0.15 | 0.30 | -0.48 | -0.13 | -0.67 |
| Normalized Diluted EPS | -0.09 | 0.19 | -0.30 | 0.01 | -0.42 |
| Average Basic Shares Outstanding | 144.79M | 144.46M | 144.35M | 143.93M | 125.32M |
| Average Diluted Shares Outstanding | 144.79M | 144.46M | 144.35M | 152.39M | 125.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |